Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Obesity

More that 1 billion of world's population is clinically obese, study shows

More than one billion people around the world are now suffering from obesity – with the number having more than quadrupled since 1990, according to a WHO study published by The Lancet medical journal.

Radio France Internationale

Government 'not doing nearly enough' to tackle obesity, says former Tory health minister

Lord Bethell tells the Standard that obesity will ‘bankrupt the country’ without urgent action

Evening Standard

More Than One Billion Now Afflicted By Obesity: Lancet

More than one billion people around the world are now suffering from obesity with the number having more than quadrupled since 1990, according to a study released by the Lancet medical journal.

International Business Times

From analysis to the latest developments in health,
read the most diverse news in one place.

More than a billion people worldwide are obese, research finds

Over past three decades. obesity rates increased fourfold among children and doubled among adults

The Guardian - UK

Oprah Winfrey announces she is stepping down from WeightWatchers

Talkshow host says she will donate all her shares ‘to eliminate any perceived conflict around her taking weight-loss medications’

The Guardian - US

Calories on menus in pubs and restaurants will save 9,000 lives, says study

Scientists say extending measures to all food outlets would reduce obesity

Evening Standard

2 Obesity Treatment Stocks Morgan Stanley Likes More than Novo Nordisk

While Novo Nordisk's Wegovy currently dominates the obesity treatment market, Morgan Stanley sees more upside potential for LLY and AZN stocks going forward.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Getting pupils to move during lessons can cut obesity, says London study

UCL scientists say reducing sedentary time in classroom can reduce weight by 8%

Evening Standard

Weight-Loss Drugs Have One Big Problem. These Drugmakers Are Taking It On.

Weight-loss drugs from Novo Nordisk and Eli Lilly lead to massive weight loss. But not all of that weight loss is healthy.

Investors Business Daily

Europe's Most Valuable Stock Is a Must-Own Near 52-Week Highs

Despite concerns over its ability to meet surging semaglutide demand, this Danish pharmaceutical giant holds a dominant position in the diabetes and insulin markets - and now commands the lead in Europe's stock market, too. Here's why NVO is a must-own stock.

Barchart

The Tories have ruined our health. These are the three things Labour must do to repair the damage

Childhood obesity and demoralised NHS staff are among the biggest problems for Keir Starmer, says Prof Devi Sridhar, chair of global public health at the University of Edinburgh

The Guardian - UK

Weight-loss drugs aren't a magic bullet. Lifestyle changes are key to lasting health

A doctor argues that the current focus on fighting obesity with drugs like Ozempic ignores the bigger picture: We need a medical system and society that support healthy life habits.

WEKU

Do fermented foods aid in weight loss?

"A systematic review of all studies that looked at the impact of fermented foods on satiety . . . showed no effect"

Salon

Weight-loss drugs need to become cheaper, says AstraZeneca boss

Loss of muscle mass also flagged, as UK drugmaker works with China’s Eccogene on obesity and type 2 diabetes pill

The Guardian - UK

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Viking Therapeutics Charges To A Record High On An Update For Its Eli Lilly-Rivaling Obesity Drug

Viking Therapeutics moved up its timeline for an Eli Lilly-rivaling obesity treatment on Thursday, leading VKTX stock to a record high.

Barchart

Novo Nordisk vs. Eli Lilly: Which Mega-Cap Healthcare Stock is a Better Buy for 2024?

Healthcare stocks LLY and NVO have crushed broader market returns in the past two decades. But with competition heating up over obesity drugs, which mega-cap stock is a better buy today?

Dynamite News

Weight loss surgery is more effective in controlling hypertension rates

Bariatric surgery is more effective at controlling hypertension rates, or high blood pressure, in people with obesity and uncontrolled high blood pressure, than blood pressure medication alone. Read further on Dynamite News:

Investors Business Daily

Amgen Is Trying To Take On Lilly, Novo In Obesity Treatment — Here's Why Lilly Stock Just Hit A Record

Amgen stock slumped Monday — as Eli Lilly stock hit a record high — after the company unveiled preclinical results for its weight-loss drug.

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

AMGN Earnings Spotlight: Analyzing Potential Gains

Drug manufacturer Amgen Inc. (AMGN) is actively pursuing strategic collaborations and making noteworthy strides in the realm of obesity treatments. With the company all set to lift the curtains on its fiscal fourth-quarter earnings tomorrow, would it be prudent to take a bullish stance on the stock now? Keep reading…

Dynamite News

Three meals of kimchi per day may lower men's obesity risk

Kimchi is made by salting and fermenting vegetables with various flavourings and seasonings, such as onion, garlic, and fish sauce. Read further on Dynamite News:

The Guardian - UK

Free school meals ‘cut obesity and help reading skills’ in England, study finds

Labour MPs call to extend provision to every primary pupil in England after study finds health and learning improve

Top News

Terry Dubrow endorses Ozempic for weight loss, dismisses Tylenol dangers

Terry Dubrow, star of Botched, advocates for the use of Ozempic for weight loss, claiming it is safer than Tylenol and effective in treating obesity.

Medical Daily

Daily 3 Servings Of Kimchi Could Reduce Risk Of Obesity In Men: Study

The researchers explored if regular consumption of kimchi could cut the risk of overall obesity, and abdominal obesity, which is particularly harmful to health.

The Guardian - UK

Obesity drug boom pushes Novo Nordisk shares to record high

Market value of Danish drugmaker behind Wegovy and Ozempic tops $500bn as demand soars

International Business Times

Weight-loss Drug Maker Novo Nordisk's Profit Surges As Sales Boom

Danish pharmaceutical giant Novo Nordisk posted bumper profits for 2023 on Wednesday, driven by blockbuster sales of diabetes and obesity treatments that helped it become Europe's most valuable company.

1 … 18 19 20 21

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the World Health Organization

the University of Edinburgh

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.